LEGN — Legend Biotech Balance Sheet
0.000.00%
Last trade - 00:00
- $9.63bn
- $8.65bn
- $285.14m
- 65
- 10
- 28
- 26
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F/A | 20-F/A | 20-F/A | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 159 | 506 | 884 | 1,027 | 1,309 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 30 | 82.5 | 58.3 | 45.5 | 157 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 212 | 594 | 950 | 1,099 | 1,498 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 73 | 112 | 141 | 161 | 189 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 293 | 722 | 1,119 | 1,331 | 1,849 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 94.2 | 116 | 229 | 298 | 216 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 141 | 124 | 354 | 587 | 597 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 151 | 598 | 766 | 744 | 1,251 |
Total Liabilities & Shareholders' Equity | 293 | 722 | 1,119 | 1,331 | 1,849 |
Total Common Shares Outstanding |